Grace Therapeutics raises $4 million through warrant exercises Oct 23, 2025 08:02AM
Grace Therapeutics receives sixth US patent for GTx-104 dosing regimen Sep 18, 2025 08:31AM
Grace Therapeutics (GRCE) Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104 Jun 25, 2025 08:03AM
TD Cowen Starts Grace Therapeutics (GRCE) at Buy May 2, 2025 05:29AM
Grace Therapeutics (GRCE) Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104 Apr 9, 2025 08:04AM


Feb 18, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Grace Therapeutics (GRCE)
Feb 10, 2025 08:05AM Grace Therapeutics (GRCE) Announces $30M Private Placement
Feb 10, 2025 08:04AM Grace Therapeutics (GRCE) Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104
Oct 25, 2024 08:01AM Acasti Pharma (ACST) Announces Corporate Name Change to Grace Therapeutics (GRCE)